Expert Says Chinese Vaccine Factory in Serbia Failed Investment | Beta Briefing

Expert Says Chinese Vaccine Factory in Serbia Failed Investment

Source: Beta
Archive / News | 15.12.23 | access_time 12:10

Zoran Radovanovic epidemiologist (printscreen: YouTube/N1)

A factory for the production of Chinese Sinopharm vaccines against the coronavirus, the construction of which started during the pandemic in Belgrade's Zemun district in 2021, is a failed investment because it cannot be repurposed to produce a different vaccine, epidemiologist Zoran Radovanovic said on Dec. 15.

"It's no good. It's like building a train and then saying: 'Oh well, let's say it's going to be an airplane, we'll modify it.' It cannot be modified because those production lines for a 'dead' vaccine are completely different from the ones for the other vaccines that have been made," Radovanovic told the Danas newspaper.

In his words, it quickly became evident during the pandemic that the Chinese vaccine provided less protection, especially to the elderly, and that the factory has been "a failed investment" from the start.

Radovanovic also believes any further work on the facility is "an additional waste of money when a lot of money has already been wasted," and that the one who made "such a stupid decision" should be called to account.

To get full access to all content of interest see our
Subscription offer
Register for free
And read up to 5 articles each month.

Already have an account? Please Log in.

Related Articles

Latest News